Given M2A Has Higher Diagnostic Yield Compared With Other Tests – CEO
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging is looking to tap into a $15 mil. U.S. irritable bowel syndrome (IBS) diagnostic market with an upcoming generation of the M2A wireless endoscopy imaging capsule with motility features